Nurix Therapeutics (NRIX) Metrics: History & Chart

Nurix Therapeutics, Inc.(NRIX)

Biotechnology · Brisbane, CA

$22.60-0.28 (-1.22%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

About Nurix Therapeutics, Inc.

Nurix Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule and antibody therapies for the treatment of cancer, inflammatory conditions, and other diseases. The company develops NX-5948, an orally bioavailable BTK degrader, that is in Phase 2 clinical trials for the treatment of relapsed or refractory B-cell malignancies and autoimmune diseases; NX-2127, an orally bioavailable Bruton’s tyrosine kinase (BTK) degrader, that is in Phase Phase 1a/1b clinical trials for the treatment of relapsed or refractory B-cell malignancies; and NX-1607, an orally bioavailable Casitas B-lineage lymphoma proto-oncogene-B (CBL-B) inhibitor, that is in Phase 1a/1b clinical trials to treat immuno-oncology indications. It is also developing NX-0479/GS-6791, a IRAK4 degrader for the treatment of rheumatoid arthritis and other inflammatory diseases. The company has a strategic collaboration agreement with Gilead Sciences, Inc. (Gilead), Sanofi S.A. (Sanofi), and Pfizer Inc. (Pfizer) for co-development and co-commercialization for multiple drug candidates. The company was formerly known as Nurix Inc. and changed its name to Nurix Therapeutics, Inc. in October 2018. Nurix Therapeutics, Inc. was incorporated in 2009 and is headquartered in Brisbane, California.

Brisbane, CA

317 employees

www.nurixtx.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Arthur T. Sands

View full financials

Third-Party DCF Estimate (FMP)	N/A
Price Gap vs Third-Party Estimate	N/A

7D Total Return	-3.34%
30D Total Return	-12.47%
YTD Total Return	+20.61%
1Y Total Return	+143.92%
3Y Total Return	+232.56%
5Y Total Return	-24.67%
10Y Total Return	N/A
15Y Total Return	N/A
20Y Total Return	N/A

2026	+20.61%
2025	+0.69%
2024	+82.56%
2023	-6.01%
2022	-62.07%
2021	-11.95%
2020

CAGR TTM	+142.89%
CAGR 3Y	+49.25%
CAGR 5Y	-5.51%
CAGR 10Y	N/A
CAGR 15Y	N/A
CAGR 20Y	N/A

PE Ratio	N/A
PE Ratio Avg TTM	N/A
PE Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

All Metrics

NRIX Valuation Metrics

NRIX Stock Price Metrics

NRIX Dividend Metrics

NRIX Growth Rate Metrics

NRIX Discounted Cash Flow Metrics

NRIX Returns By Period

NRIX Yearly Returns

NRIX Average Annual Returns By Period (CAGR)

NRIX Revenue Metrics

NRIX PE Ratio Metrics

NRIX PS Ratio Metrics

NRIX PB Ratio Metrics

NRIX Price to Free Cash Flow Ratio Metrics

NRIX Debt to Equity Ratio Metrics

NRIX PEG Ratio Metrics

NRIX FCF Yield

NRIX Earnings Yield

NRIX EBITDA Yield

NRIX OCF Yield

NRIX EV/EBIT Ratio Metrics

NRIX EV/EBITDA Ratio Metrics

NRIX EV/Assets Ratio Metrics

NRIX EV/Sales Ratio Metrics

NRIX Current Ratio Metrics

NRIX Quick Ratio Metrics

NRIX ROIC Metrics

NRIX Return on Assets Metrics

NRIX Return on Equity Metrics

NRIX Net Profit Margin Metrics

NRIX Gross Profit Margin Metrics

NRIX Tax Rate Metrics

PS Ratio	69.13
PS Ratio Avg TTM	20.04
PS Ratio Avg 3Y	16.80
Current VS TTM Avg	+244.93%
Current VS 3Y Avg	+311.41%
Current VS 5Y Avg	+319.21%

PB Ratio	6.31
PB Ratio Avg TTM	4.32
PB Ratio Avg 3Y	3.47
Current VS TTM Avg	+45.94%
Current VS 3Y Avg	+81.68%
Current VS 5Y Avg	+123.61%

PFCF Ratio	221.46
PFCF Ratio Avg TTM	126.91
PFCF Ratio Avg 3Y	126.91
Current VS TTM Avg	+74.50%
Current VS 3Y Avg	+74.50%
Current VS 5Y Avg	+74.50%

Debt/Equity Ratio	0.14
Debt/Equity Ratio Avg TTM	0.13
Debt/Equity Ratio Avg 3Y	0.10
Current VS TTM Avg	+13.25%
Current VS 3Y Avg	+45.30%
Current VS 5Y Avg	+95.27%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	0.45%
FCF Yield Avg TTM	2.55%
FCF Yield Avg 3Y	2.55%
Current VS TTM Avg	-82.38%
Current VS 3Y Avg	-82.38%
Current VS 5Y Avg	-82.38%

Earnings Yield	N/A
Earnings Yield Avg TTM	N/A
Earnings Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	N/A
Ev/Ebit Ratio Avg TTM	N/A
Ev/Ebit Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebitda Ratio	N/A
Ev/Ebitda Ratio Avg TTM	N/A
Ev/Ebitda Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Assets Ratio	4.73
Ev/Assets Ratio Avg TTM	3.15
Ev/Assets Ratio Avg 3Y	2.22
Current VS TTM Avg	+49.97%
Current VS 3Y Avg	+112.78%
Current VS 5Y Avg	+155.86%

Ev/Sales Ratio	68.87
Ev/Sales Ratio Avg TTM	21.31
Ev/Sales Ratio Avg 3Y	16.01
Current VS TTM Avg	+223.24%
Current VS 3Y Avg	+330.26%
Current VS 5Y Avg	+330.76%

Current Ratio	6.34
Current Ratio Avg TTM	6.31
Current Ratio Avg 3Y	5.37
Current VS TTM Avg	+0.50%
Current VS 3Y Avg	+18.13%
Current VS 5Y Avg	+18.15%

Quick Ratio	6.34
Quick Ratio Avg TTM	6.31
Quick Ratio Avg 3Y	5.37
Current VS TTM Avg	+0.50%
Current VS 3Y Avg	+18.11%
Current VS 5Y Avg	+18.09%

ROIC	(77.92%)
ROIC Avg 3Y	(54.02%)
ROIC Avg 5Y	(48.15%)
Current VS 3Y Avg	-44.24%
Current VS 5Y Avg	-61.83%
Current VS 10Y Avg	-71.76%

ROA	(63.74%)
ROA Avg TTM	(13.14%)
ROA Avg 3Y	(11.22%)
Current VS TTM Avg	-385.25%
Current VS 3Y Avg	-468.18%
Current VS 5Y Avg	-555.26%

ROE	(84.78%)
ROE Avg TTM	(61.47%)
ROE Avg 3Y	(58.51%)
Current VS TTM Avg	-37.92%
Current VS 3Y Avg	-44.90%
Current VS 5Y Avg	-58.89%

Net Profit Margin	(928.44%)
Net Profit Margin Avg TTM	(830.80%)
Net Profit Margin Avg 3Y	(361.35%)
Current VS TTM Avg	-11.75%
Current VS 3Y Avg	-156.94%
Current VS 5Y Avg	-160.29%

Gross Profit Margin	77.55%
Gross Pft Margin Avg TTM	(232.61%)
Gross Pft Margin Avg 3Y	(157.00%)
Current VS TTM Avg	+133.34%
Current VS 3Y Avg	+149.40%
Current VS 5Y Avg	+133.77%

Tax Rate	(0.29%)
Tax Rate Avg 3Y	(0.11%)
Tax Rate Avg 5Y	5.28%
Current VS 3Y Avg	-169.77%
Current VS 5Y Avg	-105.50%
Current VS 10Y Avg	-109.33%